EP 1075275 A1 20010214 - USE OF INTERLEUKIN-18 AS VACCINE ADJUVANT
Title (en)
USE OF INTERLEUKIN-18 AS VACCINE ADJUVANT
Title (de)
ERWENDUNG VON IL-19 ALS IMPSTOFFADJUVANS
Title (fr)
EMPLOI DE L'INTERLEUKINE 18 COMME PRODUIT D'ADDITION POUR VACCIN
Publication
Application
Priority
- EP 99920854 A 19990504
- EP 9903098 W 19990504
- EP 98201451 A 19980507
Abstract (en)
[origin: WO9956775A1] The present invention relates to the use of interleukin-18 (IL-18) as a vaccine adjuvant, adjuvant compositions and vaccines comprising said IL-18, and various recombinant IL-18 to be used in said compositions and vaccines.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01); A61P 37/04 (2006.01); C07K 14/54 (2006.01); C12N 15/24 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP US)
A61K 39/39 (2013.01 - EP); A61P 37/04 (2018.01 - EP); C07K 14/54 (2013.01 - EP); A61K 39/00 (2013.01 - EP US); A61K 48/00 (2013.01 - EP); A61K 2039/51 (2013.01 - EP); A61K 2039/55527 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9956775 A1 19991111; AU 3827699 A 19991123; CA 2328059 A1 19991111; EP 1075275 A1 20010214; JP 2002513547 A 20020514
DOCDB simple family (application)
EP 9903098 W 19990504; AU 3827699 A 19990504; CA 2328059 A 19990504; EP 99920854 A 19990504; JP 2000546799 A 19990504